Successfully Executing Oncology Trials

Supporting Oncology Clinical Trials

At Celerion, we understand the importance of timing, experience and flexibility for the successful execution of an oncology study. Celerion has successfully supported oncology studies covering over 25 indications within this complex therapeutic area. Our experience across disease states, counties and therapeutic modalities will add value to your study by providing access to key investigators, experienced study centers, networks of specialized labs (CTC/DTC/PBMC), insightful study design and highly skilled project teams. Celerion has designed and conducted programs in the rapidly expanding area of immuno-oncology in indications such as NSCLC, prostate cancer, ovarian cancer and colorectal carcinoma, to name a few.

Celerion’s clinical research professionals have the extensive experience and expertise to help you manage your complex oncology patient studies, and can help you to transition through Proof of Concept and beyond. More than any other therapeutic area, oncology products follow an unconventional path to registration. For many, combination Phase I/II or II/III studies will be a part of this plan. Celerion has significant experience in assisting clients with novel and adaptive design study protocols. Everything from complex sample size determination to PK/PD modeling to DSMB set-up and conduct, Celerion can provide a turnkey solution to these novel programs.

Celerion’s team works within a robust Quality Management System to ensure high-quality results demanded of a highly regulated industry. This helps you to save precious time and budget with experienced project managers and streamlined processes. We provide you with valuable insight from protocol development through study conduct and analysis through Celerion’s accumulated experience of nearly 1000 studies in over 30 countries. We help you mitigate risk through early problem identification, implementation of mitigation strategies, and through close monitoring of project plans and key project and decision drivers. All facets of your clinical study are closely coordinated between functional areas based on Celerion’s streamlined communication and our flat organizational structure which facilitates execution by well-trained and organized teams with rapid access to senior management. Celerion employs a CORE Monitoring approach which consists of a compliance-oriented monitoring process and is designed to take into account the specific details of not only each particular project but each study site as well. If your study or circumstances require it, we can deploy risk-based monitoring or a custom plan. For all of these solutions, Celerion assures compliance and data integrity.